oto-413
Generic: brain-derived neurotrophic factor (BDNF)
oto-413: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| OTONOMY, INC. (OTIC) | Phase 2 |
Get deeper analysis on oto-413
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis